Cargando…
SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine.
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346938/ https://www.ncbi.nlm.nih.gov/pubmed/34357399 http://dx.doi.org/10.1001/jamanetworkopen.2021.19741 |
_version_ | 1783734962993758208 |
---|---|
author | Anderson, Mark Stec, Michael Rewane, Ayesan Landay, Alan Cloherty, Gavin Moy, James |
author_facet | Anderson, Mark Stec, Michael Rewane, Ayesan Landay, Alan Cloherty, Gavin Moy, James |
author_sort | Anderson, Mark |
collection | PubMed |
description | This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine. |
format | Online Article Text |
id | pubmed-8346938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-83469382021-08-20 SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine Anderson, Mark Stec, Michael Rewane, Ayesan Landay, Alan Cloherty, Gavin Moy, James JAMA Netw Open Research Letter This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine. American Medical Association 2021-08-06 /pmc/articles/PMC8346938/ /pubmed/34357399 http://dx.doi.org/10.1001/jamanetworkopen.2021.19741 Text en Copyright 2021 Anderson M et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License. |
spellingShingle | Research Letter Anderson, Mark Stec, Michael Rewane, Ayesan Landay, Alan Cloherty, Gavin Moy, James SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine |
title | SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine |
title_full | SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine |
title_fullStr | SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine |
title_full_unstemmed | SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine |
title_short | SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine |
title_sort | sars-cov-2 antibody responses in infection-naive or previously infected individuals after 1 and 2 doses of the bnt162b2 vaccine |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346938/ https://www.ncbi.nlm.nih.gov/pubmed/34357399 http://dx.doi.org/10.1001/jamanetworkopen.2021.19741 |
work_keys_str_mv | AT andersonmark sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine AT stecmichael sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine AT rewaneayesan sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine AT landayalan sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine AT clohertygavin sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine AT moyjames sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine |